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To study the mechanism of gel-forming mucin packag-
ing within mucin granules, we generated human mu-
cous/goblet cells stably expressing a recombinant
MUC5AC domain fused to green fluorescent protein
(GFP). The fusion protein, named SHGFP-MUC5AC/CK,
accumulated in the granules together with native
MUC5AC. Inhibition of protein synthesis or disorgani-
zation of the Golgi complex did not result in diminished
intragranular SHGFP-MUC5AC/CK signals, consistent
with long-term storage of the fusion protein. However,
SHGFP-MUC5AC/CK was rapidly discharged from the
granules upon incubation of the cells with ATP, an es-
tablished mucin secretagogue. Several criteria indi-
cated that SHGFP-MUC5AC/CK was not covalently
linked to endogenous MUC5AC. Analysis of fluorescence
recovery after photobleaching suggested that the intra-
granular SHGFP-MUC5AC/CK mobile fraction and mo-
bility were significantly lower than in the endoplasmic
reticulum lumen. Incubation of the cells with bafilomy-
cin A1, a specific inhibitor of the vacuolar H
-ATPase,
did not alter the fusion protein mobility, although it
significantly increased (20%) the intragranular
SHGFP-MUC5AC/CK mobile fraction. In addition, the
granules in bafilomycin-incubated cells typically exhib-
ited a heterogeneous intraluminal distribution of the
fluorescent fusion protein. These results are consistent
with a model of mucin granule intraluminal organiza-
tion with two phases: a mobile phase in which secretory
proteins diffuse as in the endoplasmic reticulum lumen
but at a lower rate and an immobile phase or matrix in
which proteins are immobilized by noncovalent pH-de-
pendent interactions. An intraluminal acidic pH, main-
tained by the vacuolar H-ATPase, is one of the critical
factors for secretory protein binding to the immobile
phase and also for its organization.
The mucous blanket that covers the gastrointestinal, tra-
cheobronchial, urogenital, auditory, and conjunctiva epithelia
and also the gills of fishes and the epidermis of amphibians
lubricates these mucosas and creates a protective barrier
against pathogenic and noxious agents (1). This layer is a
component of the mucosal innate host response that is regu-
lated in response to inflammation and infection (2, 3). Con-
versely, overproduction of mucus can be detrimental to health,
as is evident in diseases characterized by a mucous hyper-
secretory phenotype such as cystic fibrosis (4). Proteins, glyco-
proteins, and phospholipids are an integral part of mucus, but
current evidence suggests that gel-forming mucins, together
with water and salts, largely determine the viscoelastic and
adhesive properties of mucus.
Only five different but structurally related gel-forming mu-
cins (MUC2, MUC5B, MUC5AC, MUC6, and MUC19) are
known in humans (5–12). These glycoproteins are synthesized
in and secreted from specialized cells known as mucous/goblet
cells. In the endoplasmic reticulum, mucin precursors are N-
glycosylated and likely C-mannosylated (6, 13) and form disul-
fide-linked dimers (14–17). In the different compartments of
the Golgi complex, mucin dimers are O-glycosylated and sul-
fated (6). Once they reach the acidic trans-Golgi compartments,
mucins are assembled into large covalent disulfide-linked oli-
gomers/multimers (6, 18, 19). Certain mucins are proteolyzed
to some extent in the latter compartments (20, 21).
Fully processed mucins are stored in large secretory vesicles
known as mucin granules, which occupy the majority of the
cytoplasm in mucous/goblet cells (22, 23). A combination of mucin
granules released at a very low rate and/or small secretory ves-
icles departing from the trans-Golgi compartments might medi-
ate constitutive mucin secretion (23, 24). In addition, Ca2-reg-
ulated discharge of mucin granules can be rapidly triggered by a
wide variety of physiological agents, including cytokines/chemo-
kines, bacterial exoproducts, nucleotides, neurotransmitters, and
proteases (25). Regulated secretion guarantees a high supply of
mucins in a minimal period of time, e.g. in response to acute
microbial infection or the sudden presence of noxious chemicals.
An efficient mechanism of mucin packing within secretory gran-
ules is critical to attain this function.
The mechanism of protein concentration in secretory granules
has attracted great attention over the years (26). It has been
proposed that secretory products in granules form insoluble ag-
gregates and/or are entrapped in a condensed matrix that fully
constrains their mobility and ultimately permits high concentra-
tions of the product to be attained (27, 28). In the case of mucin
granules, the matrix is postulated to be constituted by condensed
mucin multimers (29), which are also the major secretory prod-
uct. In other cell types, however, the major secretory products
might co-aggregate with intraluminal matrix proteins.
Morphological evidences suggest that, upon fusion of the gran-
ule with the plasma membrane, the mucin matrix undergoes
massive swelling with the discharge of accompanying secretory
products (30). Because mucin matrix swelling can be prevented
by increasing the extracellular Ca2 concentration and decreas-
ing its pH, it was proposed that these two factors are critical for
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mucin intragranular condensation (29, 30). Consistent with this
notion, electron microscopy microanalysis suggests the existence
of a high concentration of Ca2 in the mucin granules, whereas in
vivo measurements with pH-dependent fluorescent dyes suggest
an acidic intraluminal environment (31–33). Alternatively, an
ion exchange-triggered phase transition from a dehydrated/con-
densed mucin matrix to fully hydrated mucus might explain the
experimental observations (30).
The large size, polymeric nature, high charge density, and
hydrodynamic radii of mucins suggest the existence of a com-
plex mechanism of intragranular accumulation. These macro-
molecules have multiple specific domains and post-transla-
tional modifications (6). It is likely that they are critical for
mucin condensation and play specific roles in the overall proc-
ess. As a first step to study these issues, we modified an
existing human colonic mucous/goblet cell line to stably express
a recombinant mucin domain fused to green fluorescent protein
(GFP).1 We report the characterization of this system and the
analysis of mucin granule lumen by photobleaching techniques
in live cells. The results strongly suggest that the mucin gran-
ule lumen comprises two components: a pH-dependent immo-
bile phase and a fluid/mobile phase. The biological significance
of granule compartmentalization is discussed.
EXPERIMENTAL PROCEDURES
Cloning of MUC5AC and MUC5B CK Domains, Construction of
Plasmid Expression Vectors, and Murine Leukemia Virus Vector
Production—cDNAs encoding MUC5AC and MUC5B CK (cystine-knot)
subdomains were generated by PCR using human airway cDNA as
template and oligonucleotide pairs (MGW Biotech Inc.) based on their
reported sequences (GenBankTM/EBI accession numbers AJ001402 and
XM039877). Airway cDNA was prepared with SuperScript II RNase H
reverse transcriptase (PerkinElmer Life Sciences) from RNA purified
from well differentiated human primary airway epithelial cells as de-
scribed (34). The amplified mucin cDNA fragments were initially cloned
in the vector pCR2.1TOPO (Invitrogen) and then subcloned into pSH-
GFP, a plasmid that encodes a His-tagged secreted form of GFP (13), to
create plasmids pSHGFP-MUC5AC/CK and pSHGFP-MUC5B/CK.
These plasmids encode fusion proteins (denoted SHGFP-MUC5AC/CK
and SHGFP-MUC5B/CK, respectively) consisting of an N-terminal sig-
nal peptide, following by six consecutive histidines, GFP, and the entire
CK domain of MUC5AC (Fig. 1) or MUC5B. Murine leukemia retroviral
vectors were made by PCR amplification of SHGFP-MUC5B/CK and
SHGFP-MUC5AC/CK sequences from the previous two vectors and sub-
cloning of the resulting DNA fragments between the XbaI and HindIII
restriction sites of pHIT-XIP, a retroviral plasmid that encodes a puro-
mycin-resistant marker. pHIT-XIP was derived from pHIT-LZ (35) by
replacing the lacZ gene with a cassette containing a multiple cloning
site sequence, the poliovirus internal ribosome entry site sequence, and
the puromycin resistance gene. The resulting vectors were used to
produce replication-deficient murine leukemia virus particles in 293T
cells according to standard procedures (35). All of the plasmids men-
tioned above were analyzed by restriction nuclease digestion and DNA
sequencing (University of North Carolina DNA Sequencing Facility)
and found to have the expected DNA sequences. pssGFP-KDEL, a
plasmid that encodes a soluble GFP sorted to the endoplasmic reticu-
lum lumen, was a generous gift from Dr. E. L. Snapp (Albert Einstein
College of Medicine).
Transient Expression and Biochemical Analysis of Recombinant Pro-
teins in COS-7 Cells—COS-7 cells were grown in 25-cm2 flasks, trans-
fected with FuGENE 6 (Roche Applied Science), and radiolabeled 24 h
post-transfection with [35S]cysteine/methionine as described (36), ex-
cept that Pro-mix (Amersham Biosciences) was used as the source of
radiolabeled amino acids. Absorption of His-tagged proteins to TALON-
IMAC (identated methal affinity chromatography) beads (Clontech) and
analysis of the proteins by SDS gel electrophoresis/autoradiography
were performed as described (16).14C-Methylated proteins (Amersham
Biosciences) used as molecular mass standards were 14C-methylated
myosin (220,000 Da), phosphorylase b (97,400–100,000 Da), bovine
serum albumin (66,000 Da), ovalbumin (46,000–50,000 Da), carbonic
anhydrase (30,000 Da), and lysozyme (14,300 Da).
Permanent Expression and Biochemical Analysis of Recombinant Pro-
teins in HT29–18N2 cells—HT29–18N2 cells (a generous gift from Dr.
T. E. Phillips, Department of Biological Sciences, University of Missouri)
were maintained as described (37). Cells (2  105) were seeded in 25-cm2
T-flasks and transduced with retroviral vectors encoding SHGFP-
MUC5AC/CK or SHGFP-MUC5B/CK at a multiplicity of infection of 100
following published protocols (35). 48 h later, the cells were moved to
15-cm diameter dishes in culture medium containing 1 g/ml puromycin.
The selection medium was changed every 5 days until resistant cells were
confluent. Individual cell clones expressing the recombinant protein were
obtained by limiting dilution of the polyclonal cell line or by fluorescence-
activated cell sorting carried out at the University of North Carolina Flow
Cytometry Facility. Both polyclonal cells and single cell clones under 20
passages were employed in this study.
The biochemical identification of endogenous MUC5AC and recom-
binant His-tagged proteins synthesized by transfected cells was per-
formed by protein blotting using rabbit anti-MUC5AC polyclonal anti-
body (38) and mouse anti-His tag monoclonal antibody (Amersham
Biosciences), respectively. Total (cellular or culture medium) proteins
were separated on agarose gels and blotted onto nitrocellulose mem-
branes as described (39).
Morphological and Cytochemical Analysis of Fixed Cells—Cells were
fixed for 10 min in 4% (w/v) freshly prepared paraformaldehyde in
phosphate-buffered saline (PBS) and embedded in paraffin after etha-
nol dehydration. Sections (5 m thick) were stained with hematoxylin/
eosin and the Alcian blue/periodic acid-Schiff reaction. Some sections
were deparaffinized with xylene; rehydrated; and stained with rabbit
polyclonal antibody against GFP (Abcam) following standard proce-
dures, including antigen retrieval with citric acid, sequential incuba-
tions with appropriate goat biotinylated secondary antibodies (Jackson
ImmunoResearch Laboratories, Inc.), horseradish peroxidase (HRP)-
conjugated avidin, and the peroxidase substrates diaminobenzidine and
H2O2. Sections were counterstained with 1% (w/v) methyl green in
methanol, which stained nuclei and mucin granules in mucous/goblet
cells, likely due to their polyanionic character. Control sections were
processed with normal anti-rabbit or anti-mouse IgG.
In other experiments, cells were briefly washed with PBS contain-
ing calcium and magnesium (1 mM each) and fixed in 2% (w/v) freshly
prepared paraformaldehyde in PBS for 20 min on ice. Following a
10-min incubation in 0.1% (v/v) Triton X-100 in PBS and an overnight
incubation at 4 °C in PBS containing 0.1% (w/v) bovine serum albu-
min, the cells were sequentially incubated at room temperature with
primary and secondary antibodies (30 min each, both diluted in PBS
containing 0.1% (w/v) bovine serum albumin). After several washes
with PBS, cells were visualized under a confocal microscope within
3 h. Mouse anti-MUC5AC monoclonal antibody 45M1 (40) was ob-
tained from Lab Vision Corp. The epitope recognized by the anti-
MUC5AC monoclonal antibody is not located in the CK domain, and
therefore, this antibody detects endogenous MUC5AC, but not
SHGFP-MUC5AC/CK.
To visualize the ultrastructure of cells under an electron microscope,
cells were fixed in 1% (w/v) osmium tetroxide in perfluorocarbon, dehy-
drated in 100% ethanol, and embedded in Epon resin following published
procedures (41). Sections (90 nm thick) were selected for evaluation.
Live Cell Imaging—Cells in CO2-deficient medium plus 1% (v/v) fetal
bovine serum, 5 mM L-glutamine, and 20 mM HEPES (pH 7.8) (see Figs.
2–5) or in Hanks’ balanced salt solution plus 1% fetal bovine serum, 5
mM L-glutamine, essential and nonessential amino acids, and 20 mM
HEPES (pH 7.8) were observed using a Zeiss LSM 510 laser scanning
1 The abbreviations used are: GFP, green fluorescent protein; CK,
cystine knot; PBS, phosphate-buffered saline; HRP, horseradish perox-
idase; FRAP, fluorescence recovery after photobleaching; Mf, mobile
fraction.
FIG. 1. Schematic structure of the protein encoded by pSH-
GFP-MUC5AC/CK. The fusion protein has an N-terminal signal pep-
tide (SP), followed by six consecutive histidine residues (H6) and the
entire enhanced GFP (EGFP) sequence that precedes the CK domain of
MUC5AC. The amino acid residues in the boundary region between the
enhanced GFP sequence and the CK domain are indicated. The residues
resulting from the cloning strategy are shown in italics, and the first
N-terminal residues of the CK domain are underlined.
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confocal microscope (University of North Carolina M. Hooker Micros-
copy Facility) at 37 °C on the microscope stage using 488-nm laser
excitation for GFP.
Analysis of Fluorescence Recovery after Photobleaching (FRAP)—
Live cells were imaged at 37 °C on the temperature-controlled stage of
the Zeiss LSM 510 laser scanning confocal microscope using the 488-nm
line of a 30-milliwatt argon laser and an oil immersion objective (63,
1.4 numerical aperture). SHGFP-MUC5AC/CK fluorescence in a de-
fined region of the mucin granule or the endoplasmic reticulum was
photobleached for seven iterations for a total time period of 0.07 s at
80% laser power/100% transmission. In the case of the granules, the
bleached region was a circular spot with the width of the laser beam (i.e.
radius (r) of 0.26 m). The fluorescence intensity (F) in the bleached
area was monitored as a function of time after bleaching by scanning at
80% laser power/0.5% transmission every 0.3–0.7 s. As judged by
bleaching entire granules, SHGFP-MUC5AC/CK photobleaching under
these conditions was irreversible. Data sets with incomplete recoveries
or in which the focal plane shifted were discarded by visual inspection
of the recorded images. To assess differences in SHGFP-MUC5AC/CK
mobility in the mucin granules under different conditions, we deter-
mined the characteristic diffusion times or recovery half-times (t1⁄2), i.e.
the time required for F to recover to 50% of the plateau fluorescence
intensity (Fm), from the recovery curves of normalized (fractional) flu-
orescence intensities versus corrected times (42). Thus, the data were
fitted to a one-phase exponential curve: F(t)  Fm(1  e
kt) and t1⁄2  ln
2/k, where k is the rate constant. Although the differences in t1⁄2 ob-
tained were minimal, an exponential expression fitted the data better
than a hyperbolic equation or the expression of Feder at al. (43).
Differences in SHGFP-MUC5AC/CK mobility between the granule
and endoplasmic reticulum were assessed by determining the apparent
or effective diffusion coefficients (Deff) (40), defined as the mean squared
displacement of SHGFP-MUC5AC/CK over time. Deff integrates the
absolute diffusion coefficient, which is largely due to the viscosity of the
compartment, and effects caused by interactions and collisions with
other proteins components. Because these organelles have very differ-
ent geometries, they did not comply with the assumptions of a single
diffusion model, and therefore, different methods were applied. Intra-
granular Deff values were approximated by the expression of Axelrod et
al. (44) as modified by Wey et al. (45) for a disk system of radius R
bleached in a circular spot of radius r, which has a size 40% of the
system size: Deff  ((r
2/4t1⁄2)(1  1.8(r/R))), where  is a correction
factor for the amount of bleaching (44), which in our case was 1.35. As
applied to the granule, the model assumed that recovery of the fluores-
cence within the bleached spot was caused by radial (rather than axial)
diffusion of SHGFP-MUC5AC/CK, which is a reasonable assumption
(46, 47) considering that (a) FRAP analysis was carried out with a 1.4
numerical aperture objective, and hence, a substantial region in the
axial direction was also bleached during the photobleaching pulse; and
(b) SHGFP-MUC5AC/CK had a low intragranular mobility (see “Re-
sults”). Only granules with diameters of 1.1 m or larger in which the
fluorescence was homogeneously distributed were chosen for Deff anal-
ysis. Larger granules minimized the possibility of overestimating Deff
values that might result from the limited quantities of fluorescent
SHGFP-MUC5AC/CK molecules outside the bleached spot (45, 48).
SHGFP-MUC5AC/CK Deff in the endoplasmic reticulum was estimated
by bleaching a 2-m width strip and subsequent analysis of the recov-
ery data with the simulation program of Siggia et al. (49).
SHGFP-MUC5AC/CK mobile fraction (Mf) values, defined as the
percentages of fluorescent SHGFP-MUC5AC/CK capable of diffusing
into the bleached region during the time of the experiment, were esti-
mated by the procedure of Feder et al. (43) as modified by Lippincott-
Schwartz and co-workers (42), which corrects for the background fluo-
rescence and the loss of fluorescence during the bleaching pulse and
subsequent imaging of the granule.
Fitting the data to the above expressions was done by least-squares
nonlinear regression. In each case, the goodness of fit was assessed by
plotting the data and examining the corresponding error standard and
coefficient of determination (R2). The sizes of the samples were chosen
such that the 95% coefficient intervals of the mean values were equal to
or less than mean  (2  S.E.). The differences in the SHGFP-
MUC5AC/CK mean t1⁄2 and Mf values between control and bafilomycin-
treated cells were analyzed by Student’s t tests.
RESULTS
The CK Domains in MUC5AC and MUC5B Form Disulfide-
linked Homodimers—To visualize mucin granules in live cells,
we employed GFP technology in HT29–18N2 cells, a human
colon cell line known to differentiate into mucous/goblet cells
when grown in a defined serum-free culture medium (37). A
priori, a fusion protein between GFP and a protein domain in
the mucin polypeptide had a reasonable chance to interact with
endogenous mucin and to be transported eventually into the
mucin granule. We chose the CK-like domain because it is a
short domain (100 amino acid residues) present at the C
termini of all human and animal gel-forming mucins known (6,
50). Expression studies have suggested that the CK domains in
porcine submaxillary mucin (porcine MUC19) (14, 15), rat
MUC2 (16), and MUC2 (17) are involved in the formation of
disulfide-linked dimers early in the process of mucin multim-
erization (6). The high degree of protein conservation among
gel-forming mucins strongly suggested that the CK domains in
MUC5AC and MUC5B are also dimerization domains. To test
this possibility, COS-7 cells were transfected with expression
plasmids encoding fusion proteins containing the signal pep-
tide of the murine Ig -chain, followed by six consecutive his-
tidine residues and the MUC5AC or MUC5B CK domain.
In this study, control cells were transfected with the parental
vector pSecTag2A, which lacks mucin-coding sequences. 24 h
after transfection, the cells were incubated for 4 h with
[35S]cysteine/methionine, and the mucin CK domains were iso-
lated from the medium by adsorption to and elution from a
methal affinity adsorbent. The eluates were analyzed by reduc-
ing SDS gel electrophoresis and autoradiography (Fig. 2). Al-
though no specific proteins were detected in the medium of
untransfected cells (lane 1) or cells transfected with the paren-
tal plasmid (lane 2), two major and closely migrating protein
bands were detected in the medium of cells expressing
MUC5AC/CK (lane 3) or MUC5B/CK (lane 4). A third, less
abundant protein with a higher electrophoretic mobility was
judged to be a proteolyzed CK domain based on its apparent
molecular mass. In both cases, the smaller of the two major
purified proteins had a molecular mass of 20 kDa, which was
consistent with the expected molecular mass deduced from the
corresponding cDNA sequences of SHGFP-MUC5AC/CK and
SHGFP-MUC5B/CK. The larger proteins were judged to corre-
spond to N-glycosylated species based on their sensitivity to
tunicamycin, an inhibitor of protein N-glycosylation, which
allowed detection of only the smaller species (data not shown).
The respective CK domains in MUC5AC and MUC5B have a
conserved Asn-X-(Ser/Thr) peptide motif. It is therefore not
surprising that they were secreted from COS-7 cells as a mix-
FIG. 2. Expression and secretion of the MUC5AC and MUC5B
CK domains. Untransfected COS-7 cells (lanes 1 and 5) and cells
transfected with the expression plasmids pSecTag2 (lanes 2 and 6),
pMUC5AC/CK (lanes 3 and 7), and pMUC5B/CK (lanes 4 and 8) were
metabolically labeled with 35S-labeled amino acids 24 h post-transfec-
tion. Proteins were purified from the culture medium with TALON-
IMAC (identated methal affinity chromatography) beads and separated
by reducing SDS gel electrophoresis with (lanes 1–4) or without (lanes
5–8) prior reduction of the proteins with 2-mercaptoethanol. The gels
were dried, and bands were detected by fluorography. The molecular
weights (MW) of the standards are in thousands.
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ture of unglycosylated and N-glycosylated species. Previous
studies have demonstrated N-glycosylation of the CK domain
in porcine MUC19/porcine submaxillary mucin (14, 15). Over-
expression of the domains likely indicated that a significant
portion of the recombinant proteins were not N-glycosylated, as
reported in previous experiments with recombinant porcine
MUC19/porcine submaxillary mucin (14).
Under nonreducing conditions, no bands were observed in
the medium of untransfected cells (Fig. 2, lane 5) or cells
transfected with the parental plasmid (lane 6), whereas a broad
band centered at 40 kDa was purified from the medium of
cells expressing MUC5AC/CK (lane 7) or MUC5B/CK (lane 8),
indicating that these recombinant proteins formed disulfide-
linked dimers. These results suggest that the MUC5AC and
MUC5B CK domains, like the corresponding domains in por-
cine MUC19/porcine submaxillary mucin (15), rat MUC2 (16),
and MUC2 (17), are N-glycosylated domains involved in the
formation of disulfide-linked dimers during the assembly of the
multimeric species of these mucins (6). The experiments in this
study were focused on the CK domain of MUC5AC, and studies
on the MUC5B CK domain are currently in progress.
SHGFP-MUC5AC/CK Is Expressed and Co-localized with
Native Mucins in Mucous/Goblet Cells—pSHGFP-MUC5AC/CK
directs the synthesis of a fusion protein between GFP and the
MUC5AC CK domain with a signal peptide and six histidines
at the N terminus. C-terminal (rather than N-terminal) GFP
fusion proteins were used for two major reasons. First, the CK
domain is found only at the C termini of mucins and other
proteins (6). Second, studies by Forstner and co-workers (51)
suggest that the most C-terminal amino acid residues of the rat
MUC2 CK domain are important for dimerization. When ex-
pressed in non-mucin-producing cell lines (including COS-7,
Chinese hamster ovary, Madin-Darby canine kidney, and 3T3)
or in undifferentiated HT29–18N2 cells stably expressing
SHGFP-MUC5AC/CK (HT29-SHGFP-MUC5AC/CK cells),
SHGFP-MUC5AC/CK was predominantly distributed in a
perinuclear region and in a reticular network coming off the
nuclear envelope, characteristic of the Golgi complex and the
endoplasmic reticulum, respectively. Consistent with this con-
clusion, a fusion protein between red fluorescent protein and
the galactosyltransferase trans-Golgi retention signal co-local-
ized with SHGFP-MUC5AC/CK in the perinuclear region.2
Preliminary studies indicated that, in non-mucin-producing
cells, SHGFP-MUC5AC/CK had an intracellular distribution
typical of a secreted protein synthesized in the endoplasmic
reticulum and transported through the Golgi complex prior to
its secretion. Indeed, SHGFP-MUC5AC/CK could be detected
in the culture medium of transfected cells by Western blotting
with anti-His antibody or after TALON-IMAC (identated
methal affinity chromatography) absorption of 35S-labeled
proteins secreted in the medium (data not shown).
HT29–18N2 is a human mucin-secreting colon adenocarci-
noma cell line derived from HT29 cells that exhibits an undif-
ferentiated phenotype in the presence of serum. However,
when these cells are cultured at high cell densities in a defined
serum-free medium, a fraction of the cells undergo a differen-
tiation process into goblet-like cells within the next 1–2 weeks
(37). These cells synthesize MUC2 and MUC5AC, which are
found in large mucin granules. We generated HT29–18N2 cells
stably expressing SHGFP-MUC5AC/CK by retroviral trans-
duction and subsequent selection of positive cells in selective
culture medium. Both polyclonal and monoclonal cell lines
expressing the recombinant mucin were screened for GFP ex-
pression, isolated, and expanded. With respect to the experi-
ments presented in this study, polyclonal and monoclonal cells
produced the same results.
HT29-SHGFP-MUC5AC/CK cells chemically fixed and pro-
cessed for electron microscopy revealed that mucous cells were
not present after 3 days in serum-free medium (Fig. 3A, panel
a), whereas they were abundant 8 days later (panel b). These
cells characteristically appeared with much of their cytoplasm
filled with large granules in one pole and the nucleus in the
opposite side (panel b; also see below). Mucous cells also exhib-
ited the characteristic goblet morphology on hematoxylin/eo-
sin-stained sections of cells previously embedded in paraffin2 J. Perez-Vilar, manuscript in preparation.
FIG. 3. Characterization of chemically fixed cells. A, cells grown
for 3 days (panel a) or 8 days (panel b) in serum-free medium were
processed for electron microscopy and observed under an optical micro-
scope. Scale bars  5 m. B, cells grown for 15 days in serum-free
medium were fixed with paraformaldehyde, dehydrated, and embedded
in paraffin, and sections were processed for hematoxylin/eosin (panel a)
or periodic acid-Schiff (panel b) and observed under an optical micro-
scope. Scale bars  10 m. C, cells processed as described for B were
deparaffinated with citric acid, rehydrated, and stained with IgG/HRP-
conjugated anti-rabbit IgG (panel a) or anti-GFP antiserum/HRP-con-
jugated anti-rabbit IgG (panel b), and the HRP reaction was developed
with H2O2/diaminobenzidine and observed under an optical microscope.
A brownish precipitate indicates a positive reaction. Scale bars  10
m. D, cells grown for 8 days in serum-free medium were fixed with
paraformaldehyde, permeabilized with buffered Triton X-100, stained
with anti-MUC5AC monoclonal antibody/rhodamine-conjugated anti-
mouse monoclonal antibody, and observed under a confocal laser mi-
croscope. In panel c, the pink signal indicates the location of endogenous
MUC5AC (panel a); the green color corresponds to SHGFP-
MUC5AC/CK fluorescence (panel b); and the white signal indicate co-
localization of both signals. The asterisk in panel c indicates the nucleus
of a goblet cell expressing SHGFP-MUC5AC/CK and recognized by
anti-MUC5AC monoclonal antibody. Scale bar  6 m. E, mucous/
goblet cells in cultures grown for 8 days in serum-free medium and
processed for electron microscopy (panels a–c). N, nucleus; MG, mucin
granules; MV, microvilli; CM, cell-surface mucus. Scale bars  3 m
(panels a and b) and 2 m (panel c).
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(Fig. 3B, panel a). Furthermore, mucous cells were heavily
stained with the carbohydrate-reactive periodic acid-Schiff re-
agent (panel b), which likely reflected the abundance of mucins.
To demonstrate the presence of SHGFP-MUC5AC/CK in the
mucous cells, deparaffinated sections of paraformaldehyde-
fixed cells were incubated with rabbit IgG (Fig. 3C, panel a) or
rabbit anti-GFP antiserum (panel b), followed by HRP-conju-
gated anti-rabbit antibody. After incubation in peroxidase sub-
strates, the sections were counterstained with methyl green,
which endowed mucin granules and nuclei with a dark-gray
color. The positive brownish reaction, which was absent in cells
immunostained with control rabbit IgG (panel a), was clearly
visible over the mucin granules when the sections where im-
munostained with anti-GFP antibody (panel b). Localization of
endogenous MUC5AC in paraffin-embedded cells was not pos-
sible with monoclonal antibody 45M1, likely because the
epitope recognized by this antibody was destroyed during the
processing of the cells. However, we could detect endogenous
MUC5AC in paraformaldehyde-fixed, Triton X-100-permeabi-
lized HT29-SHGFP-MUC5AC/CK cells using the same anti-
MUC5AC monoclonal antibody and a fluorescently labeled sec-
ondary antibody (Fig. 3D). The fluorescent signals associated
with MUC5AC (panel a) and SHGFP-MUC5AC/CK (panel b)
co-localized in mucous cells (white signal in panel c). However,
not all the cells showed co-localization, likely reflecting both
incomplete antibody penetration and loss of SHGFP-MUC5AC/
CK fluorescence during fixation/processing of the cells.
When examined by electron microscopy, cultures of differen-
tiated HT29-SHGFP-MUC5AC/CK cells had numerous mu-
cous/goblet cells with large electron-lucent mucin granules
(Fig. 3E, panels a–c). The mucous cells had microvilli on their
apical surface, and their endoplasmic reticulum and Golgi com-
plex could be seen in some (but not all) cells. Taken together,
these results show that HT29-SHGFP-MUC5AC/CK cells were
able to differentiate into mucous/goblet cells, which synthe-
sized SHGFP-MUC5AC/CK as part of their repertoire of secre-
tory proteins, including MUC5AC. Consistent with this conclu-
sion, expression of MUC5B, MUC2, and TFF3 (trefoil factor-3)
was detected by reverse transcription-PCR (data not shown).
SHGFP-MUC5AC/CK Is Preferentially Located in Mucous
Granules of Live Mucous/Goblet Cells—The cytochemical char-
acterization of chemically fixed cells strongly suggested that
SHGFP-MUC5AC/CK was located in the mucin granules. Con-
sistent with these observations, live cell imaging of differenti-
ated cultures showed that SHGFP-MUC5AC/CK was found
mainly in cells with large vesicular structures (Fig. 3, A and B)
that had diameters in the same range (0.5–2.0 m) as the
mucin granules observed in chemically fixed cells. These gran-
ules did not co-localize with markers for the endoplasmic retic-
ulum, Golgi complex, or endosomes/lysosomes.2 Mucin gran-
ules occupied one side of the cell, whereas the nucleus was in
the opposite pole (Fig. 4C), as was also evident in fixed goblet
cells visualized under an electron microscope (see above). The
percentages of mucous cells varied with the age of the culture
and from culture to culture, but values of up to 30% were not
uncommon. The underlying reason for this variability was not
investigated. It was evident that, in live cells, mucin granules
were separated by cytoplasmic space (Fig. 3, C and D), whereas
in fixed cells, the intergranular space was often not present
(Fig. 3, A, B, and E), suggesting that fixation and subsequent
sample processing altered the morphology of the goblet cell,
likely inducing mucin swelling and apposition. FRAP analysis
also indicated that the granules were not physically connected
(data not shown).
ATP Triggers the Discharge of SHGFP-MUC5AC/CK Accu-
mulated in Mucin Granules—The defining feature of mucous/
goblet cells is the regulated secretion of gel-forming mucins
accumulated in the mucin granules. Thus, the presence of
mucous secretagogues induces a rapid exocytosis of the gran-
ules and, eventually, secretion of large amounts of mucins.
Consequently, it was important to establish whether the
steady-state distribution of SHGFP-MUC5AC/CK in the gran-
ules reflected a true accumulation rather than a steady but
transient distribution (for instance, fast processing in and
transport out of the endoplasmic reticulum/Golgi complex and
slower transport out of the granule). For these experiments,
differentiated cells were incubated in the presence of 100 g/ml
cycloheximide, a protein synthesis inhibitor, for up to 5 h and
then examined live under a confocal microscope. In compara-
tive experiments, cells were incubated for up to 4 h with 0.1
g/ml brefeldin A, a compound that disorganizes the Golgi
complex (52). As shown in Fig. 5A, inhibition of protein syn-
thesis did not result in disappearance of SHGFP-MUC5AC/CK
from the granules. Similarly, brefeldin A did not affect intralu-
minal SHGFP-MUC5AC/CK fluorescence, although the endo-
plasmic reticulum in many of these cells had expanded subre-
gions and, in general, increased SHGFP-MUC5AC/CK
fluorescence throughout the organelle (Fig. 5B). These results
are consistent with long-term accumulation of SHGFP-
MUC5AC/CK in the mucin granules, as expected for a regu-
lated secretory granule.
FIG. 4. Mucin granules in live mucous/goblet cells. A, xy confocal
image of SHGFP-MUC5AC/CK localization in live mucous/goblet cells.
Cells were grown for 8 days in serum-free medium and observed live
under a confocal microscope at 37 °C on the microscope stage using an
oil immersion objective (63, 1.4 numerical aperture) and 488-nm laser
excitation. Scale bar  5 m. B, xz projection made from 15 confocal
images of live mucous/goblet cells expressing SHGFP-MUC5AC/CK
observed as described for A. Scale bar  5 m. C, xy imaging of a single
live mucous/goblet cell with numerous SHGFP-MUC5AC/CK-contain-
ing mucin granules. Note the cytoplasmic space separating the gran-
ules. Scale bar  3 m. D, xy three-dimensional composite image of 50
consecutive sections of a live mucous/goblet cell expressing SHGFP-
MUC5AC/CK observed at 37 °C on the microscope stage. Scale bar 
0.5 m.
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We then determined whether HT29-SHGFP-MUC5AC/CK
cells and ultimately their mucin granules are responsive to the
presence of mucous secretagogues. It has been reported that
mucous cells secrete mucins in response to ATP, a well char-
acterized purinergic mucous secretagogue (53). The optimal
concentration of ATP varies among cell types, and in the case of
HT29 cells, ATP in the millimolar range is optimal to rapidly
induce granule exocytosis (54). Therefore, we visualized live
HT29-SHGFP-MUC5AC/CK cells before and after addition of 3
mM ATP. The cells were kept at 37 °C on the confocal micro-
scope stage in a buffered HCO3-free physiological medium and
studied by time-lapse imaging. SHGFP-MUC5AC/CK fluores-
cence within both the granule and endoplasmic reticulum was
recorded. However, to visualize the fluorescent signal in the
latter organelle, the fluorescence intensity in the granules was
saturated. Fig. 5C shows how a cluster of resting mucous/goblet
cells with abundant fluorescent mucin granules (panel a) lost
most of its fluorescent signal within 5 min of ATP addition
(panel b), even when the initial intragranular fluorescent sig-
nal was saturated. Although intragranular fluorescence inten-
sity followed inverse exponential kinetics (R2  0.99) with a
characteristic decay rate of 0.37 absorbance units/s, the flu-
orescence intensity in the endoplasmic reticulum linearly de-
creased with a characteristic rate of 0.08 absorbance units/s
(panel c), which was comparable with the fluorescence decay in
control cells similarly imaged. These results indicate that
SHGFP-MUC5AC/CK stored in mucin granules was dis-
charged upon ATP addition directly from the mucin granules.
Consistent with this conclusion, it has been found that mucin
exocytosis in HT29 cells is maximal within 5 min after ATP
addition (54).
SHGFP-MUC5AC/CK Is Not Covalently Linked to Endogenous
MUC5AC—In mucin-producing cells, extracellular gel-forming
mucins can be found soluble in the culture medium or in the
mucus adherent to the cell surface, likely representing freshly
secreted polymeric mucins not fully hydrated. To determine
whether SHGFP-MUC5AC/CK was present in the adherent
MUC5AC-containing surface mucus, HT29-SHGFP-MUC5AC/
CK cells grown on Transwell filters were fixed with parafor-
maldehyde and stained with anti-MUC5AC monoclonal antibody
as described for Fig. 3D, but without prior permeabilization with
Triton X-100. Fig. 6A shows xz images of HT29-SHGFP-
MUC5AC/CK cells demonstrating that SHGFP-MUC5AC/CK
(panels a and c) and MUC5AC (panels b and c) did not co-localize
in the surface mucus. Only anti-MUC5AC monoclonal antibody
stained the cell-associated mucus, whereas the SHGFP-
MUC5AC/CK signal was confined to the cells. This observation
suggests that SHGFP-MUC5AC/CK was not covalently linked to
endogenous MUC5AC, and hence, it was released into the sur-
rounding culture medium upon secretion.
The following observations are consistent with the above
conclusion. (a) Discharge of intragranular SHGFP-MUC5AC/
CK upon ATP addition did not result in localization of the
protein to the cell surface, but rapid disappearance into the
culture medium (Fig. 5C).2 (b) SHGFP-MUC5AC/CK could be
visualized outside the cells only in closed intercellular spaces
(Fig. 6B, panel a), known as mucous lakes (55). Mucous lakes,
which very likely were formed by the secretory activity of
mucous/goblet cells enclosing them (panel b), were readily iden-
tified in fixed cells visualized under an electron microscope
(panel c). The “lake” mucous matrix resembled the intragranu-
lar matrix in that both were composed of a network of fibrous
material (panel c, inset), likely representing mucin polymers
and aggregates. Indeed, the presence of MUC5AC in mucous
lakes was corroborated by immunofluorescence of fixed cells
using anti-MUC5AC antibody (data not shown). Throughout
FIG. 5. ATP-regulated discharge of intragranular SHGFP-
MUC5AC/CK in live mucous/goblet cells. A, two representative live
mucous/goblet cells visualized under a confocal microscope after 4 h in
cycloheximide-containing culture medium. Scale bar  3 m. B, a
representative live mucous/goblet cell observed under a confocal micro-
scope after 4 h in brefeldin A-containing culture medium. To visualize
SHGFP-MUC5AC/CK fluorescence in the endoplasmic reticulum, the
mucin granule signal was saturated. The inset shows a mucous cell with
an unsaturated intragranular fluorescent signal. Scale bar  2 m. C,
a cluster of live mucous/goblet cells visualized under a confocal micro-
scope before (panel a) and after (panel b) addition of ATP. Total fluo-
rescence intensities immediately following ATP addition were simulta-
neously measured in the endoplasmic reticulum and mucin granules
(panel c). The asterisks indicate the goblet cell in which fluorescence
intensities in the endoplasmic reticulum and mucin granules were
followed over time after ATP addition. Scale bars  3 m. a.u., absorb-
ance units.
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FIG. 6. SHGFP-MUC5AC/CK is not covalently associated with endogenous mucins. A, differentiated cells grown on Transwell filters for
8 days were fixed with paraformaldehyde and immunostained with anti-MUC5AC monoclonal antibody/rhodamine-conjugated anti-mouse IgG
without prior permeabilization with Triton X-100. xz scans under a confocal microscope permitted the visualization of SHGFP-MUC5AC/CK in the
cells (green signal in panels a and c) and MUC5AC in the cell-associated mucus (red signal in panels b and c). Scale bar  5 m. B, shown is an
SHGFP-MUC5AC/CK-containing mucous lake in live cultures of differentiated HT29-SHGFP-MUC5AC/CK cells (panels a and b) as observed
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this work, we will refer to mucus/mucins in mucous gels as
extracellular mucus/mucins.
To determine whether SHGFP-MUC5AC/CK immobilized in
the extracellular mucous matrix or, as expected from the above
results, freely diffused through it, mucous lakes were analyzed
by FRAP. As shown in Fig. 6C (panel a), after bleaching a 1-m
width strip, a significant and instant decrease in the fluores-
cence intensity over the entire mucous lake region, and not only
in the bleached region, was observed. The same result occurred
when the bleaching was done in a larger or smaller region.
These results are consistent with (a) very rapid equilibration of
unbleached SHGFP-MUC5AC/CK with bleached SHGFP-
MUC5AC/CK during the time scale of the experiment (42) and
(b) the presence of limiting amounts of SHGFP-MUC5AC/CK
in the mucous lakes. Indeed, inspection of the changes in flu-
orescence intensity over time showed that the pre-bleaching
intensity dropped to half its value and failed to recover (panel
b). Although quantitative estimations of diffusion were not
possible under these conditions (42), these results suggest that
the fusion protein diffused very rapidly through the extracel-
lular mucous/mucin matrix. The results support the conclusion
that SHGFP-MUC5AC/CK was not covalently linked to the
mucin polymers/aggregates in mucous lakes.
The above results strongly suggested that SHGFP-
MUC5AC/CK and endogenous mucins (MUC5AC) were not
covalently linked in the mucin granules and that, upon granule
exocytosis, SHGFP-MUC5AC/CK diffused into the culture me-
dium. This conclusion was further supported by the biochemi-
cal detection of MUC5AC and SHGFP-MUC5AC/CK in the
culture medium and cell extracts of differentiated HT29-
SHGFP-MUC5AC/CK cells, respectively. Protein secreted into
the medium and cellular proteins from differentiated cells were
separated on SDS-agarose gels with or without prior reduction
of disulfide bonds, transferred to nitrocellulose paper, and blot-
ted with anti-MUC5AC or anti-His tag antibody. Consistent
with a published report (38), unreduced MUC5AC was detected
at the top of the agarose gel as several discrete bands, likely
representing disulfide-linked forms. One polymorphic protein
band representing monomeric forms was observed on reducing
gels both in and outside the cells (Fig. 6D, panel a). In contrast,
when anti-His antibody was used without prior reduction of the
proteins, proteins only at the front (but not the top) of the gels
were detected (panel b), indicating that the SHGFP-
MUC5AC/CK protein was not disulfide-linked to endogenous
MUC5AC. Immunoblotting of proteins separated by SDS-
PAGE, transferred to polyvinylidene difluoride membranes,
and stained with anti-His tag antibody confirmed the presence
of monomeric and dimeric SHGFP-MUC5AC/CK on reducing
and nonreducing gels, respectively (data not shown). Taken
together, these results suggest that SHGFP-MUC5AC/CK and
endogenous MUC5AC did not interact through interchain di-
sulfide bonds.
A Fraction of SHGFP-MUC5AC/CK Is Mobile and Slowly
Diffuses through the Mucin Granule Lumen—That SHGFP-
MUC5AC/CK is a soluble protein, not covalently bound to
MUC5AC oligomers/multimers, permitted us to use it as a
FRAP marker for studying the mucin granule intraluminal
environment and ultimately its organization relative to the
lumen in other organelles (e.g. the endoplasmic reticulum)
involved in mucin secretion. In these experiments, we photo-
bleached a small (r  0.26 m) spot in granules with diameters
1.1 m and followed over time the recovery of the fluores-
cence in the spot. In contrast to the situation in the extracel-
lular mucus, both the bleached spot and the subsequent recov-
ery of the fluorescence in the bleached region could be clearly
visualized in all granules analyzed (Fig. 7A). These results
showed that intragranular SHGFP-MUC5AC/CK mobility and
concentration were much slower and larger, respectively, than
in the extracellular mucus. Moreover, in some granules, the
fluorescent signal in the bleached region did not entirely re-
cover during the time scale of our analyses, consistent with the
existence of a significant pool of immobile SHGFP-MUC5AC/
CK. This conclusion was further supported by the relatively
low values of asymptotic fluorescence intensities (Fm) observed
in the bleaching/recovery curves (Fig. 7B). Indeed, SHGFP-
MUC5AC/CK Mf values ranged from 12 to 61%, with a mean
of 37% (Fig. 7C), consistent with the notion that a significant
proportion of SHGFP-MUC5AC/CK was immobilized in the
granules.
It was also possible that, because of the constrained geome-
try and relatively small area of the granules, a significant
fraction of intragranular SHGFP-MUC5AC/CK fluorescence
outside the bleached spot was photobleached, resulting in un-
derestimated Mf values. As shown by Angelides et al. (48) and
assuming that all of the fluorescent protein was mobile, such
an underestimation would be significant only when the area of
the circular system is less than 4 times the area of the
bleached spot. In our FRAP analysis, only granules with diam-
eters between 1.1 and 1.8 m, i.e. corresponding to areas
4.2–10.3 times bigger than the area of the bleached spot, were
examined. Hence, assuming that all of the intraluminal
SHGFP-MUC5AC/CK protein was mobile, we would expect Mf
values between 70 and 90% (48). However, the experimental Mf
values obtained ranged in most cases from 16 to 57% (Fig. 7C)
and therefore could not be explained by the recovery of an
entirely mobile SHGFP-MUC5AC/CK pool in a constrained
system, but rather reflected the existence in the granules of a
significant immobile fraction of the fluorescent protein. Such a
conclusion is supported by the following observations: (a) the
persistence in some granules of a bleached area after the fluo-
rescence intensity reached a plateau (Fig. 7A), which indicated
that unbleached SHGFP-MUC5AC/CK outside that area was
not limiting; (b) the lack of a statistical correlation between Mf
values and the respective granule diameters (see below); and
(c) the substantial increase in intragranular SHGFP-
MUC5AC/CK Mf values when cells were incubated with bafilo-
mycin (see below).
The fluorescence recovery curves reasonably followed a one-
phase exponential equation (Fig. 7D), which permitted an es-
timate of the SHGFP-MUC5AC/CK t1⁄2, the characteristic dif-
fusion time or recovery half-time. t1⁄2 values ranged from 0.9
to 5 s. In most cases, the t1⁄2 values were between 1 and 2 s,
with a mean value of 1.3 s (Fig. 7E). The wide range of
intragranular SHGFP-MUC5AC/CK Mf and t1⁄2 values
under a confocal microscope. In most cases, mucous lakes were enclosed by goblet cells (panel b). In chemically fixed cells processed for the electron
microscope, mucous lakes were readily identified (panel c) and contained an intraluminal fibrous material similar to the intragranular matrix
(panel c, inset). Scale bar  2 m. C, a representative mucous lake was bleached (white strips), and the recovery of the fluorescence was recorded
over time. Panel a, pre-bleaching (left), immediately post-bleaching (center), and 14-s post-bleaching (right) images; panel b, the corresponding
bleaching/recovery curve of a representative analysis. Note the overall loss of fluorescence in the mucous lake immediately after the bleaching
pulse. Scale bars  5 m. a.u., absorbance units. D, secreted (M) and cellular (C) proteins of differentiated cells were separated on agarose gels,
transferred to nitrocellulose paper, and detected with anti-MUC5AC monoclonal antibody/HRP-conjugated anti-rabbit IgG (panel a) or anti-His tag
antibody/HRP-conjugated anti-mouse IgG (panel b) with (Reduced) or without (Unreduced) prior reduction with 2-mercaptoethanol. Positive bands
were detected by chemiluminescence.
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prompted us to test whether these parameters correlated with
one another or with the mucin granule diameter, which also
exhibited a wide range of values. Both Pearson’s test and
Spearman’s non-parametric test did not support the existence
of a significant correlation between any of these parameters,
although it must be considered that only granules 1.1 m in
diameter were analyzed. Collectively, these results show that
intragranular SHGFP-MUC5AC/CK molecules were distrib-
uted between a mobile phase, where they could slowly diffuse,
and an immobile phase.
SHGFP-MUC5AC/CK Mobile Fraction and Mobility in the
Endoplasmic Reticulum Are Higher than in the Mucin Gran-
ule—It was important to determine whether the SHGFP-
MUC5AC/CK highly immobile fraction and the low mobility
within the granule were the result of the intragranular envi-
ronment or, alternatively, an intrinsic property of the recom-
binant protein. To distinguish between these possibilities, we
carried out FRAP analysis in the endoplasmic reticulum. Be-
cause of the heterogeneous nature and irregular geometry of
this organelle, we used strip photobleaching, which has been
shown to provide far more consistent results than spot bleach-
ing for analyzing endoplasmic reticulum protein diffusion (42,
49, 56). As shown in Fig. 8A, unbleached SHGFP-MUC5AC/CK
apparently equilibrated with the bleached protein within 1 min
of bleaching. Moreover, in contrast to the situation in the
granules, a large portion of the pre-bleaching mean fluores-
cence intensity recovered after the bleaching pulse (Fig. 8B),
suggesting that a large fraction of SHGFP-MUC5AC/CK in this
organelle was mobile. Thus, the corresponding SHGFP-
MUC5AC/CK mean Mf was considerably higher (86%) than in
the mucin granules (Fig. 8C), indicating that the majority of
the SHGFP-MUC5AC/CK molecules were indeed mobile while
in the lumen of the endoplasmic reticulum.
SHGFP-MUC5AC/CK background-corrected fluorescence re-
covery curves followed a hyperbolic (rather than a one-phase
exponential) equation (Fig. 8C), with t1⁄2  3 s. Interestingly, this
value was of the same order of magnitude as the corresponding
parameter in the mucin granules. However, because the area
bleached in the endoplasmic reticulum (2 m2 assuming that
50% of the bleached area was occupied by elements of the
endoplasmic reticulum) was considerably larger than in the mu-
cin granules (0.238 m2), then SHGFP-MUC5AC/CK moved
substantially faster in the endoplasmic reticulum. Consistent
with this initial assessment, the SHGFP-MUC5AC/CK Deff
within the endoplasmic reticulum was almost 100-fold larger
than in the mucin granule, with mean  S.E. of 1.42  0.17
m2/s (n  34) and 0.014  0.003 m2/s (n  20), respectively.
Moreover, because of the low Mf values in the granules, intra-
granular SHGFP-MUC5AC/CK Deff values were very likely over-
estimations (48), and therefore, the differences in SHGFP-
MUC5AC/CK mobility between this organelle and the
endoplasmic reticulum might be even larger. These results indi-
FIG. 7. Mobile fraction and mobility of SHGFP-MUC5AC/CK in the mucin granule. A, representative FRAP analysis involving bleaching
of a circular spot in a mucin granule of a live mucous/goblet cell. Shown are pre-bleaching (left), immediately post-bleaching (center), and 24-s
post-bleaching (right) images at two different magnifications. A low magnification of the cell is also shown (right cell in the inset). Scale bars  0.5
or 1 m (inset). B, averaged (mean  S.E.) normalized bleaching/recovery curve for 21 granules in 21 mucous/goblet cells analyzed as described
for A. Error bars indicate S.E. C, scatter plot of the intragranular SHGFP-MUC5AC/CK Mf values in the same sample of cells analyzed as described
for B. The mean  S.E. is shown. D, normalized background-corrected averaged (mean  S.E., n  21) recovery curve for intragranular
SHGFP-MUC5AC/CK fluorescence in the bleached spot. The means  S.E. for R2 and t1⁄2 are shown. Error bars indicate S.E. E, scatter plot of the
intragranular SHGFP-MUC5AC/CK t1⁄2 values in the same sample of cells. The 95% coefficient interval is shown.
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cate that the intragranular SHGFP-MUC5AC/CK low mobility
and the high immobile fraction were not likely caused by
SHGFP-MUC5AC/CK intrinsic properties, but reflect a response
to the intraluminal environment of this organelle.
The vacuolar H-ATPase Inhibitor Bafilomycin A1 Increases
SHGFP-MUC5AC/CK Mobile Fractions in Mucin Granules—
Evidence obtained in different cell systems suggests there is a
negative pH gradient from the endoplasmic reticulum to the
Golgi complex to secretory granules (57). Indeed, using pH-
sensitive fluorescent compounds, Verdugo et al. (32) suggested
the existence of acidic pH in the mucin granule. The activity of
the vacuolar H-ATPase in the membrane of secretory gran-
ules might explain, at least in part, this gradient (26). In view
of these data, intragranular pH could be one of the factors
contributing to SHGFP-MUC5AC/CK fractionation between an
immobile phase and a slow mobile fraction. To test this hypoth-
esis, cells were incubated for up to 4 h with bafilomycin A1, a
specific inhibitor of the vacuolar H-ATPase (58). At the end of
the treatment, FRAP analysis was carried out as described
above for control cells. Although mucous/goblet cells with abun-
dant granules were present in bafilomycin-treated cultures,
many of the granules exhibited a heterogeneous distribution of
the SHGFP-MUC5AC/CK fluorescence (Fig. 9A). After bleach-
ing only granules with homogeneous fluorescence (Fig. 9B), a
prerequisite for FRAP analysis, normalized photobleaching
curves (Fig. 9C) indicated that the percent of the plateau fluo-
rescence intensity relative to the pre-bleaching intensity was
larger than in control cells (Fig. 7B). This curve profile suggests
that a higher proportion of intragranular SHGFP-
MUC5AC/CK was mobile under conditions of vacuolar H-
ATPase inhibition. Indeed, as shown in Fig. 9D, the differences
between the intragranular SHGFP-MUC5AC/CK mean Mf val-
ues in control and bafilomycin-treated cells were statistically
significant (p 	 0.001). As was the case in control cells, the
normalized photobleaching-corrected FRAP recovery curves
(Fig. 9E) followed a one-phase exponential expression with an
intragranular mean t1⁄2 value (1.7 s) statistically indistin-
guishable (p  0.834) from the corresponding parameter in
control cells (Fig. 9F), suggesting that bafilomycin did not alter
SHGFP-MUC5AC/CK mobility. These results indicate that in-
tragranular SHGFP-MUC5AC/CK immobilization was revers-
ible and dependent on the activity of the vacuolar H-ATPase,
suggesting that intraluminal pH was a critical factor for intra-
granular organization.
DISCUSSION
We have generated a mucous/goblet cell line stably express-
ing a fluorescent mucin domain accumulates in mucin gran-
ules. The fusion protein SHGFP-MUC5AC/CK consists of an
N-terminal signal peptide, followed by GFP, six consecutive
histidines, and the CK domain of MUC5AC. The CK domain is
found in the C termini of all gel-forming mucins, from fishes to
humans, and it is involved in mucin dimerization, which is the
first step in the formation of mucin covalent oligomers/multim-
ers (6). Consistent with this notion, the MUC5AC and MUC5B
CK domains were secreted from transfected cells as disulfide-
linked dimers (Fig. 2). Interestingly, whereas SHGFP-
MUC5AC/CK was secreted and could be detected free in the
extracellular mucus, it was not covalently linked to endogenous
MUC5AC (Fig. 5). These results suggest a role in dimerization
for protein sequences N-terminal to the CK domain. This pos-
sibility is also supported by expression studies in LS174T cells
showing that GFP fused to the entire C-terminal region of
MUC2 forms homodimers and also heterodimers with endoge-
FIG. 8. Mobile fraction and mobility of SHGFP-MUC5AC/CK in the endoplasmic reticulum. A, FRAP analysis involving strip bleaching
of a region comprising part of the endoplasmic reticulum of a live HT29-SHGFP-MUC5AC/CK cell. Pre-bleaching (left), immediately post-bleaching
(center), and 31-s post-bleaching (right) confocal images are shown. Scale bars  3 m. B, averaged (mean  S.E.) normalized bleaching curve for
15 live cells analyzed as described for A. Error bars indicate S.E. C, scatter plot of the SHGFP-MUC5AC/CK Mf values in the endoplasmic
reticulum. The mean  S.E. and 95% coefficient interval are shown. D, fitting of the normalized background-corrected averaged (mean  S.E.)
recovery data to a hyperbolic expression to determine t1⁄2. The corresponding mean t1⁄2 and R
2 values are shown. Error bars indicate S.E.
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nous MUC2 (17). However, the fact that MUC6, one of the two
major secreted mucins in the gastric mucosa, has only a C-
terminal CK domain and not the additional domains present in
the C-terminal region in MUC2, MUC5AC, MUC5B, and
MUC19, indicates that, if such a role indeed exists, it is not an
absolute requirement for dimerization.
Several criteria indicated that HT29-SHGFP-MUC5AC/CK
cells, like the parental cell line HT29–18N2 (37), underwent an
in vitro mucous cell differentiation process when cultured at
high density in a defined serum-free medium (Figs. 2 and 3).
Thus, up to 30% of the cells developed a mature mucous/goblet
cell phenotype, including biogenesis of abundant periodic acid-
Schiff-reactive mucin granules. The granules stored large
quantities of SHGFP-MUC5AC/CK, as judged by their intra-
granular fluorescence intensity, together with endogenous
MUC5AC. Moreover, intragranular SHGFP-MUC5AC/CK was
discharged within minutes of ATP addition (Fig. 5). Interest-
ingly, mucin granules in live mucous cells (Fig. 4) were not
apposed to the degree observed at the optical or electron mi-
croscope level (Fig. 2). Live mucous cells often seemed rather
columnar, and their granules were clearly separated by cyto-
plasmic space. These results demonstrate that the fixation and
processing of mucous/goblet cells for microscopy altered their
morphology and likely induced granule swelling.
Our FRAP analysis gave us an approximate picture of the
environment that SHGFP-MUC5AC/CK and ultimately mu-
cins face from their biosynthesis in the endoplasmic reticulum
until the moment they are stored in the mucin granules. Thus,
in the endoplasmic reticulum, the entire SHGFP-MUC5AC/CK
pool was essentially mobile (Fig. 8). Its intraluminal mean Deff
(1.4 m2/s) was consistently smaller than the reported coef-
ficient for ssGFP-KDEL (9–10 m2/s) (42, 59), but larger
than the elastase-GFP Deff (0.6 m
2/s) (60). Although the
Stokes-Einstein expression (61) indicates that diffusion is in-
versely related to the viscosity of the solution, other factors,
such as interactions or collisions with mobile or immobile in-
traluminal components (62), affect protein mobility within cell
compartments. Because the ssGFP-KDEL mean Deff in the
endoplasmic reticulum lumen of HT20–18N2 cells (9 m2/s)
(data not shown) does not differ from the values reported in
other cell types (59), then interactions of the CK domain with
other proteins (e.g. MUC5AC precursors) might explain the
relatively low mobility of SHGFP-MUC5AC/CK. As for other
cell types, the endoplasmic reticulum in mucous/goblet cells
expanded in the presence of brefeldin A (Fig. 5). This response
likely reflects the increased accumulation of mucin and other
secretory product precursors of those forms retro-transported
from the Golgi complex (54). Interestingly, preliminary studies
FIG. 9. Mobile fraction and mobility of intragranular SHGFP-MUC5AC/CK in live cells treated with bafilomycin A1. A, represent-
ative confocal xy image of a live mucous/goblet cell after 4 h in bafilomycin. The inset shows a higher magnification of a single mucin granule. Scale
bar  1 and 0.5 m (inset). B, representative FRAP analysis of a mucin granule in a bafilomycin-treated live goblet cell (A) showing pre-bleaching
(left), immediately post-bleaching (center), and 24-s post-bleaching (right) confocal images. Scale bars  0.5 m. C, averaged (mean  S.E.)
normalized bleaching/recovery curve for 16 granules in different bafilomycin-treated mucous/goblet cells analyzed as described for Fig. 7A. D,
scatter plot of the intragranular SHGFP-MUC5AC/CK Mf values in control and bafilomycin-treated live mucous/goblet cells. The respective 95%
coefficient interval and mean Mf values are shown. E, normalized background-corrected averaged (mean  S.E.) recovery curve of intragranular
SHGFP-MUC5AC/CK in bafilomycin-treated cells fitted to a one-phase exponential expression. Mean R2 and t1⁄2 values are shown. F, scatter plot
of intragranular SHGFP-MUC5AC/CK t1⁄2 values in control and bafilomycin-treated live mucous/goblet cells. The respective 95% coefficient interval
and mean t1⁄2 values are shown.
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FIG. 10. Intraluminal organization of mucin granules. A, the results reported in this study suggest the existence in the granule of a mobile
compartment in which secretory products very slowly diffuse and an immobile matrix in which the secretory products are immobilized by noncovalent
interactions. The spatial relationship between these two intraluminal subcompartments could be envisioned by two simple but antagonistic models. In
the core model, the matrix forms an inaccessible, likely dehydrated condensed core, where immobilized secretory products are entrapped during the
process of matrix condensation. The mobile compartment with the mobile fraction would be positioned around the core, and therefore, exchange of
mobile and immobile products would be limited with the interface between both subcompartments. In the meshwork model, the immobile, likely
condensed matrix forms a three-dimensional network embedded in the mobile fraction, which has access to every region of the network. Therefore,
exchange of mobile and immobile species could take place throughout the entire matrix network. These models predicted different FRAP outcomes, as
shown by the schematics representing hypothetical granules prior to bleaching (p), immediately after bleaching (b), and at equilibrium post-bleaching
(pb). Note that the core model predicts the absence of fluorescence recovering in the bleached area. Our FRAP analysis showed that 1) immobile and
mobile SHGFP-MUC5AC/CK proteins were homogeneously distributed in the granule, 2) SHGFP-MUC5AC/CK fluorescence recovered in the bleached
area, and 3) SHGFP-MUC5AC/CK redistribution after the bleaching was homogeneous. As indicated under “Discussion,” these results favor a
three-dimensional meshwork model. B, shown is an xy confocal image of mucin granules with fluorescence-free cores in a live mucous/goblet cell
scanned as described for Fig. 4. Scale bar  0.5 m. C, shown are representative FRAP xy images of a core mucin granule (upper panels) showing
pre-bleaching (left), immediately post-bleaching (center), and 24-s post-bleaching (right) images and the corresponding normalized bleaching curve
(lower panel). Scale bars  0.5 m. D, shown is a schematic representing the organization of granules with fluorescence-free cores following the
meshwork model for intragranular organization. The expected FRAP pre-, immediately post-, and post-bleaching images are indicated.
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suggest that SHGFP-MUC5AC/CK mobility in the endoplasmic
reticulum of brefeldin A-treated cells did not differ compared
with control cells. If confirmed, these results will further sug-
gest that SHGFP-MUC5AC/CK mobility is governed by inter-
actions of the CK domain with other components of the endo-
plasmic reticulum.
The intragranular SHGFP-MUC5AC/CK Deff was 2 orders of
magnitude smaller than in the endoplasmic reticulum, sug-
gesting that the intragranular medium was especially viscous;
the fusion protein collided and/or interacted with other luminal
compounds. Moreover, even assuming large intragranular con-
centrations of Ca2 and other cations, hindrance due to charge
interactions involving the polyanionic mucin matrix and
SHGFP-MUC5AC/CK cannot be ruled out. Indeed, the com-
plexity of the intragranular environment is easily revealed by
plotting the recovery radial intensities as a function of granule
diameter at each post-bleaching time point. None of these
curves could be fitted to a gaussian expression, indicating that
intragranular SHGFP-MUC5AC/CK movement cannot be ex-
plained by simple diffusion (data not shown). In any case,
similar Deff values for intragranular SHGFP-MUC5AC/CK are
found only in slowly diffusing membrane receptors (44). In
contrast to the situation in the endoplasmic reticulum, a sig-
nificant fraction of intragranular SHGFP-MUC5AC/CK was
immobile during the time scale of the experiments. It is gener-
ally assumed that the granule intraluminal matrix is mainly
constituted by condensed mucin networks (29, 30), likely bound
to Ca2, although the exact packing mechanism is unknown. In
any case, a long-term strong interaction between SHGFP-
MUC5AC/CK and the condensed mucin matrix could explain
our results, suggesting that a similar mechanism might permit
intragranular accumulation of non-mucin secretory proteins
(e.g. lysozyme and TFF3) in mucous cells.
Intragranular SHGFP-MUC5AC/CK immobilization could
be reversed by inhibiting the activity of the vacuolar H-
ATPase, as judged by the increase in its mean Mf value (Fig. 9).
Although studies on the localization of vacuolar H-ATPase in
mucous/goblet cells are not yet available, the current evidence
suggests that this protein resides in the secretory granule
membrane, where its activity is critical for maintaining an
acidic intraluminal pH (26, 63, 64). Hence, by inhibiting the
vacuolar H-ATPase, the intragranular pH very likely in-
creased, and ionic and/or hydrophobic interactions important
for SHGFP-MUC5AC/CK immobilization and also matrix orga-
nization (e.g. condensation/decondensation of mucin oligomers/
multimers) were eventually lost. For instance, the theoretical
and empirical pI values for SHGFP-MUC5AC/CK and GFP (65)
suggest that the fusion protein is negatively charged at the pH
of the endoplasmic reticulum lumen, but likely uncharged
while in the granule. Thus, charge neutralization might permit
protein-protein hydrophobic interactions and ultimately
SHGFP-MUC5AC/CK immobilization.
Intragranular SHGFP-MUC5AC/CK fluorescence appeared
to be homogeneously distributed in most of the granules in
control cells and, after a bleaching pulse, did not show a pref-
erential redistribution to certain areas. Interestingly, in bafilo-
mycin-treated cells, intragranular SHGFP-MUC5AC/CK dis-
tribution was often irregular (Fig. 9A), likely reflecting a
structural disorganization of the intragranular matrix. These
observations support the existence of a pH-dependent tri-di-
mensional meshwork-type (rather than a compact and inacces-
sible) intragranular matrix. This matrix would be likely em-
bedded in a mobile phase in which secretory products could
very slowly diffuse (Fig. 10A). The matrix network might create
a steric hindrance that contributes to the slow intragranular
diffusion of proteins in the mobile fraction. A similar two-phase
model is also suggested by studies on the mechanism of intra-
granular Ca2/K ion exchange (66, 67).
Our results do not rule out the formation of granule cores,
which were inaccessible to the SHGFP-MUC5AC/CK mobile
fraction. Indeed, a small percentage of untreated mucous/gob-
let cells (5%; n  104) had granules with fluorescence-free
centrally located cores (Fig. 10B). It is possible that, in these
cores, immobilized SHGFP-MUC5AC/CK had lost its emission
or, alternatively, that the fusion protein never had access to the
interior. In any case, FRAP analysis of the core granules did
not indicate heterogeneous redistribution of SHGFP-
MUC5AC/CK fluorescence (Fig. 10C), consistent with the ex-
istence of a three-dimensional network, likely a pH-dependent
matrix in the rest of the granule (Fig. 10D). The observation
that bafilomycin only increased the intraluminal SHGFP-
MUC5AC/CK Mf value up to 20% over untreated cells is
consistent with the existence of other factors affecting granule
matrix organization and protein accumulation. Whatever these
additional factors may be, their effects were rapidly neutral-
ized during regulated secretion, as suggested by the rapid
disappearance of intragranular SHGFP-MUC5AC/CK fluores-
cence upon ATP addition (Fig. 5). Indeed, once SHGFP-
MUC5AC/CK was secreted and reached the extracellular space
(i.e. the mucous lakes), there was a sharp increase in its mo-
bility (Fig. 6). These results are consistent with the existence of
an intragranular condensed mucin matrix and its subsequent
expansion upon exocytosis, as proposed in the ion exchange-
triggered phase transition model of granule exocytosis (29, 30,
68, 69).
In summary, our results suggest that the mucin granule
lumen is compartmentalized into a mobile fraction, where se-
cretory products are able to diffuse, albeit very slowly, and into
a pH-dependent immobile matrix, where secretory proteins are
retained by a pH-dependent mechanism. The incorporation of
secretory products from a mobile into an immobile osmotically
inert phase would permit the packing of large amounts of
secretory products. In addition, mucin granule compartmental-
ization may have important functions beyond its role in the
mechanism of mucin/protein packaging. Thus, intraluminal
Ca2 in the mobile fraction might be critical for the regulation
of granule exocytosis (67). Alternatively, a mobile phase might
make it possible for certain late pH-dependent mucin modifi-
cations, including disulfide bonding through D domains (18,
19), proteolytic processing (20), and even terminal glycosyla-
tion, to continue in the granule.
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